Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jun 17, 2020 (6 years ago)

Famotidine Injection

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Cause type: Temperature excursion

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled. All temperature excursion recalls.

What was recalled

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Affected NDC 63323-0739-12

Compare with the code on your package — it is the most precise check available.

Drug: Famotidine Category: Heartburn & Stomach Medication

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Famotidine
NDC 63323-0739
10 mg/mL Injection, Solution
Intravenous
Fresenius Kabi USA, LLC Rx
Recalling firm
HF Acquisition Co. LLC
NDC code
63323-739-12
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1392-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Famotidine recalls

See all
Class I · High risk

Famotidine Injection

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Ongoing Microbial contamination Fresenius Kabi USA, LLC NDC 63323-739-11 D-0182-2026
Class II · Moderate risk

Famotidine Tablets

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Terminated Labeling / mix-up Glenmark Therapeutics, Inc. NDC 72657-113-20 D-0939-2023
Class II · Moderate risk

Famotidine Tablets USP 40mg

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-860-99 D-0290-2021

Other recalls by HF Acquisition Co. LLC

All 2020 recalls